ArticleFrontiers in cardiovascular medicine2022

Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration.

Jochen Dutzmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.